The company had posted a net profit of Rs 29.07 crore for the corresponding period of previous fiscal.
Net sales of the company, however, rose to Rs 203.78 crore for the third quarter, as against Rs 166.31 crore for the same period of 2011-12 fiscal, Jyothy Laboratories Ltd said in a BSE filing.
"Our new team is in place and has taken charge of restructuring and rationalising of different verticals. We are confident that all these efforts will help us in improving our margins," Jyothy Laboratories Chairman and Managing Director M P Ramachandran said.
He added that the company has "strategised plans for some brands which will be beneficial for the company going forward".
The company would further strengthen its global operations with the start of its Bangladesh unit by the end of FY13, Ramachandran said.
Jyothy Laboratories markets various brands, including Ujala, Maxo, Exo and Henko.
Shares of Jyothy Laboratories today settled higher by 1.64% at Rs 145.65 on the BSE.